Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

FDA panel votes against ecstasy for PTSD

It's a big setback for the effort to mainstream psychedelic drugs.

Axios

Up Over 700% YTD, Here's How Much Higher Analysts Think This Biotech Stock Can Rise

As the biotech industry rebounds from recent challenges, a favorable regulatory environment and groundbreaking scientific advancements are creating investment opportunities, particularly in companies with robust clinical pipelines and promising early-stage data.

Barchart

1 Penny Stock Where You Can Spend Less And Earn More

This tiny stock could soar more than 400%, according to Wall Street.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication

Federal health advisers are considering the first request to approve the mind-altering club drug MDMA as a treatment for PTSD

The Independent UK

What is SPF and how much sunscreen do you really need? Experts answer

Skin cancer is the most common cancer in the US and while sunscreen abounds in aisles, many aren’t applying it correctly

The Guardian - US

European sunscreens offer better protection, dermatologist says

A growing number of Americans have reason to question the safety and efficacy of U.S. sunscreens.

Axios

3 Biotech Stocks With Potential Breakthroughs Emerging

The biotech industry's future is promising, driven by advanced technologies like AI and VR, the rising popularity of personalized treatments, and increased R&D spending. Let's analyze the investment prospects of biotech stocks Amgen (AMGN), United Therapeutics (UTHR), and Gilead Sciences (GILD) as potential breakthroughs emerge. Read more.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

This Surging Small-Cap Biotech Has One Very High-Profile Investor

Humacyte is a pre-revenue biotech company that has delivered outsized gains to shareholders in 2024. But is the small-cap stock a good buy right now?

Barchart

3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference for Wood's disruptive approach to investing, may find these stocks particularly compelling.

Barchart

Landmark review spotlights challenge of judging psychedelic therapies

FDA advisers this week will scrutinize what could become the first approved psychedelic drug.

Axios

Smart rings will stay niche until they add these missing features

Smart rings are getting more popular by the year, but there are a few things keeping them from really breaking into the mainstream. Here's my wishlist for what these smart rings could really use.

Android Central

Can psychedelics treat depression? Maybe, and you might not even have to take a trip

The use of the drugs in treating low mood has sparked debate, not least about the necessity of a hallucinogenic experience. But a new discovery may provide an answer

The Guardian - UK

California's Tortilla Bill Threatens To Flatten Small Businesses

Proposed legislation mandates folic acid in masa flour, sparking fears among traditional tortilla makers about costs and cultural impact.

Reason

The battle for MDMA as drug steps closer to becoming a prescription medicine

MDMA could be reclassified as a prescription medicine and made available to specially certified doctors and therapists

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Guillain-Barre Syndrome 'More Common Than Expected' In RSV Vaccinated Older Adults: CDC

While the U.S. Food and Drug Administration (FDA) and the officials from the CDC continue to investigate the risks, the current recommendation is to continue the vaccine as "the estimated benefits of RSV vaccination continued to outweigh potential risks."

Fortune

A major nicotine company went through New Yorkers’ thrown-out vapes and found that 99% were illegally imported from China

Vapes with candy-like flavors such as “blue razz ice” and “pink lemonade” dominated the study.

International Business Times UK

First Pill for Postpartum Depression Offers New Hope for New Mothers

Before the new oral medication, women experiencing postnatal depression were prescribed an intravenous injection which risks excessive sedation and a sudden loss of consciousness.

Fortune

Ozempic and Wegovy are so hard to find that a startup invented a free tool for tracking whether the weight-loss drugs are in stock

The tool, from telehealth company Ro, lets users report when they find the drug in stock and when there’s a shortage.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Rishi Sunak ordered by High Court judge to come clean on first Rwanda flight date

Government lawyers had told the court flights could go in late June – but then Rishi Sunak called the election

Marie Claire

Gwyneth Paltrow is thought to be a fan of red light therapy for your vagina - so, can it really boost pelvic floor tone and sexual function?

Helpful tool or harmful fad?

StockNews.com

Dividend Stability and Growth in Pharma: Pfizer (PFE) vs. Bristol-Myers Squibb (BMY)

The pharma sector is primed for solid growth owing to technological advancements, growing healthcare needs, and a rise in chronic diseases. Given this backdrop, let’s analyze the fundamentals of pharmaceutical stocks Pfizer (PFE) and Bristol-Myers Squibb (BMY) to determine which of these stocks offer better dividend stability and growth. Read…

Fortune

Could drugs like Ozempic and Wegovy help people live longer? Some experts see them as potential longevity pills

“The singular most effective and consistent way of extending lifespan in animals is caloric restriction.”

International Business Times UK

Neuralink's First Brain Implant Patient Shares 'Amazing and Rewarding' Experience

The first paralysed man with a Neuralink chip reports success (racing games!), but software updates and brain response pose challenges.

Salon

Louisania GOP passes abortion pill ban

Under the proposed law, people found in possession of the pills could face up to five years behind bars

International Business Times UK

Ark Invest CEO Cathie Wood Boosts Stake in Firms Making Breakthroughs in Gene Editing, AI Drug Development, and Obesity Drugs

Cathie Wood splurged millions in biotech this year on strong clinical progress, AI adoption, sales growth, wider outreach, and steady product pipelines.

1 … 97 98 99 100

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.